Legal Opinion
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Court of Appeals for the Federal Circuit
Decided September 12, 2013No. 2012-1498, 2012-1499UnpublishedCited by 5 opinions
1Opinion of the Court
O’MALLEY, Circuit Judge.
This patent infringement suit arises from Abbreviated New Drug Applications (“ANDAs”) filed by Teva Pharmaceuticals USA Inc. (“Teva”) and Par Pharmaceutical, Inc. and Par Pharmaceutical Compa nies, Inc. (collectively “Par”) (with Teva, collectively “Appellants”). Through their ANDAs, Appellants seek to market generic versions of Lovaza®, a pharmaceutical product marketed by Plaintiff Pronova BioPharma Norge AS (“Pronova”). Following a bench trial, the U.S. District Court for the District of Delaware entered final judgment for Pronova, holding that U.S. Patent Nos.…
2Cases cited13 opinions
- W.L. Gore & Associates, Inc., Appellant/cross-Appellee v. Garlock, Inc., Appellee/cross-AppellantCourt of Appeals for the Federal Circuit · 1983
- Pfaff v. Wells Electronics, Inc.Supreme Court of the United States · 1998
- Moleculon Research Corporation v. Cbs, Inc.Court of Appeals for the Federal Circuit · 1986
- Egbert v. LippmannSupreme Court of the United States · 1881
- Invitrogen Corp. v. Biocrest Manufacturing, l.p.Court of Appeals for the Federal Circuit · 2005
8 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- I.E.E. International Electronics & Engineering, S.A. v. TK Holdings Inc.District Court, E.D. Michigan · 2014
- BNJ Leasing, Inc. v. Portabull Fuel Service, LLCDistrict Court, S.D. Mississippi · 2022
- Bam Bags, LLC v. Zip-It Ltd.District Court, S.D. New York · 2019
- Belcher Pharmaceuticals, LLC v. Hospira, Inc.District Court, D. Delaware · 2020
- Ni-Q, LLC v. Prolacta Bioscience, Inc.District Court, D. Oregon · 2019